Levetiracetam Zentiva (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A in the brain, which modulates neurotransmitter release. This action stabilizes neuronal firing and diminishes excessive excitability, thereby lowering the likelihood of seizure propagation.

The appropriate dose of Levetiracetam Zentiva is determined by the prescribing clinician based on the patient’s age, weight, renal function, and seizure type. Dosage adjustments are made individually and should follow the prescriber’s instructions.

Safety data for levetiracetam in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made in consultation with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Levetiracetam has a distinct mechanism targeting SV2A, which differs from sodium‑channel blockers like carbamazepine or GABA‑enhancers such as phenobarbital. It is generally well tolerated, has fewer drug‑enzyme interactions, and does not require routine therapeutic drug monitoring, making it a convenient option for many patients.

Store Levetiracetam Zentiva at temperatures below 25 °C, in its original packaging, and protect it from moisture and direct sunlight. Keep the product out of reach of children and avoid exposing it to excessive heat or humidity.

Levetiracetam Zentiva is taken orally, usually with or without food, as directed by the prescriber. The tablets should be swallowed whole with water and not crushed or chewed unless specifically advised by a healthcare professional.

Serious risks include severe allergic reactions such as Stevens‑Johnson syndrome, significant mood changes like depression or suicidal thoughts, and rare hematologic abnormalities. Patients should seek immediate medical attention if they develop rash, unexplained bruising, or marked changes in mood.

Levetiracetam is contraindicated in individuals with known hypersensitivity to levetiracetam or any of its excipients. Caution is also advised for patients with severe renal impairment, as dose adjustments are required, and for those with a history of psychiatric disorders.